Reducible PEG-POD/DNA Nanoparticles for Gene Transfer In Vitro and In Vivo: Application in a Mouse Model of Age-Related Macular Degeneration
Non-viral gene delivery systems are being developed to address limitations of viral gene delivery. Many of these non-viral systems are modeled on the properties of viruses including cell surface binding, endocytosis, endosomal escape, and nuclear targeting. Most non-viral gene transfer systems exhib...
Saved in:
Main Authors: | Bhanu Chandar Dasari (Author), Siobhan M. Cashman (Author), Rajendra Kumar-Singh (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PEG Conjugated Zein Nanoparticles for In Vivo Use
by: Courtney van Ballegooie, et al.
Published: (2022) -
CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
by: Dongchun Xie, et al.
Published: (2024) -
Nanotechnology for Age-Related Macular Degeneration
by: Bo Yang, et al.
Published: (2021) -
Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
by: Lorenzo Ferro Desideri, et al.
Published: (2023) -
Protective effect of ghrelin in oxidative stress-induced age-related macular degeneration in vitro and in vivo
by: Jie Bai, et al.
Published: (2024)